[218 Pages Report] The global anastomosis devices market is projected to reach USD 2.9 billion by 2024 from an estimated USD 2.1 billion in 2019 at a CAGR of 7.2% during the forecast period. The growth of this market is primarily driven by the increasing incidence of target diseases and the subsequent growth in the number of surgical procedures, growing demand for minimally invasive surgeries, and technological advancements.

However, the high cost of devices and the extensive clinical…

The fetal monitoring market is expanding with the latest innovative technologies, backed by escalating research and product launches. Fetal monitoring technologies are now being streamlined to provide greater assistance in utero fetal surgeries, consisting of challenging physical fetal access and technological complications. Fetal cardiac assessments have also witnessed progress that supports high-fidelity hemodynamic and continuous physiologic monitoring, thus enabling early diagnosis and…

The presence of a large geriatric and target patient population and the improving healthcare infrastructure in several APAC countries are expected to offer growth opportunities in the market during the forecast period. 

The market for osteoarthritis therapeutics is anticipated to be marginally affected due to the outbreak of COVID-19. Among drug types, the use of corticosteroids has reduced. Although there is no evidence to suggest that corticosteroid injections lead to a substantial…

The COVID-19 outbreak is an unprecedented global public health challenge and is expected to have a significant impact on the blood collection devices market.

Both hospital and independent laboratories are generally reviewing each test to decide whether to recommend consultations with laboratory hematologists for tests with a higher risk profile or not offer tests that could not be performed safely. This affected the market negatively in the first few months of the pandemic, reducing…

The growth of this market is majorly driven by the rising demand for sterilized pharmaceutical formulations, increasing demand for medical devices. The technological advancements in cleanroom technology along with the increasing demand for cleanroom technologies in developing economies are expected to offer significant opportunities for market growth in the coming years. 

The technical limitations associated with their operational costs and technical challenges associated with the…

The pandemic has also resulted in disruptions in the supply chain, affecting the global medical devices industry. The pandemic has adversely impacted global financial expectations, supply chain, operations, and crisis response plans. The manufacturers of advanced wound care products faced disruptions owing to the spread of COVID-19, leading to lockdowns and travel restrictions.

The manufacturing of advanced wound care products was significantly affected as major economies were…

The major factors driving the growth of this market include the increasing incidence of infectious diseases, the rising number of accidents & trauma cases, the emergence of liquid biopsy tests, and a demand for blood donations and blood components.  

Both hospital and independent laboratories are generally reviewing each test to decide whether to recommend consultations with laboratory hematologists for tests with a higher risk profile or not offer tests that…

It involves the non-cancerous enlargement of the prostate gland. While BPH rarely shows symptoms before the age of 40, the risk of contracting BPH increases with age. The condition affects nearly 50% of men between the ages of 51 and 60 and up to 90% of men older than 80. Treatment measures such as medications and surgery have been used for patients with BPH.

The prostate health market witnessed a loss of business, and the trend continued till late December 2020. Unfavorable changes…

The growing geriatric population and increasing incidence of chronic diseases; the growing focus on food sterilization and disinfection; technological advancements in sterilization equipment; and the increasing outsourcing of sterilization services among pharmaceutical companies, hospitals, and medical device manufacturers. The growing number of medical device and pharmaceutical companies in emerging economies, increasing use of E-beam sterilization, re-introduction of ethylene oxide…

The major factors driving the growth of the market are the increasing number of infertility cases, rising awareness about IVF treatment, and growing number of IVF clinics.

With the increasing number of infertility cases, the demand for IVF treatment is also increasing. Infertility is caused due to various reasons such as PCOS, endometriosis, uterine fibroids, etc. According to WHO, around 48.5 million women worldwide suffer from infertility. IVF is one of the most effective treatments…

The market for osteoarthritis therapeutics is anticipated to be marginally affected due to the outbreak of COVID-19. Among drug types, the use of corticosteroids has reduced. Although there is no evidence to suggest that corticosteroid injections lead to a substantial increase in the risk of infection, there is a possible reduction in the immune response for up to a few weeks following the procedure. While this risk is extremely low, it needs to be considered when deciding to proceed with…

[ 187 Pages Report] The global medical ceramics market is projected to reach USD 12.9 billion by 2025 from USD 9.6 billion in 2020, growing at a CAGR of 5.9% from 2020 to 2025. Increasing research activities for the development of novel medical ceramics, growing demand for medical ceramics in plastic surgeries & wound healing applications; the rising number of hip & knee replacement procedures; and the increasing demand for implantable devices are responsible for the significant…

The global health crisis triggered by the COVID-19 pandemic has made it imperative that the pharmaceutical industry moves at a rapid pace alongside researchers, regulators, and contract research companies to develop a diagnosis, treatment, and vaccines. Cleanroom technologies and services play an important role in this scenario to ensure that quality, safety, and efficacy are being maintained.

In the current scenario, the healthcare industry is witnessing an unparalleled demand for…

Based on product, the healthcare asset management market is segmented into radiofrequency identification (RFID) devices, real-time location systems (RTLS), and ultrasound & infrared tags. Of all these product segments, the RFID devices segment is expected to account for the largest share of the healthcare asset management market in 2018. RTLS on the other hand is expected to register the highest CAGR during the forecast period owing to the higher precision and accuracy offered by RTLS…

The market trends is driven by the increasing prevalence of diabetes, the high incidence of obesity, and the increasing number of surgical procedures across the globe. In line with this, the major trend in this market is the acquisition of small players by prominent players. 

Players operating in the market are altering their long-term and short-term growth strategies by tapping the research market and developing innovative products to combat the pandemic. Even though the impact of…

The global real world evidence solutions market is expected to reach USD 2.3 billion by 2026, according to a new report by MarketsandMarkets. The market is anticipated to witness a CAGR of 14.4% during the forecast period. Rising adoption of big data analytics in the healthcare sector and government initiatives to promote the use of real world evidence are expected to drive the market growth over the forecast period. 

In addition, increasing use of electronic health records (EHRs) and…

According to the WHO ICTRP and the NIH ClinicalTrials.gov databases, 27 clinical investigations of MSC-based cell therapy approaches have begun in China since the onset of the COVID-19 outbreak, as well as a growing number of academic and industry trials elsewhere. Regenerative medicine & stem cell research is one of the major applications of cell expansion. This is a major indicator of market growth as stem cell-based therapies are showing significant potential in COVID-19 study.…

The development of therapies for key diseases, such as cancer, has attracted significant attention. Furthermore, increasing investments of pharmaceutical companies in the development of novel drugs is also fueling the market growth. However, significant operational costs are expected to negatively impact the cell & gene therapy manufacturing market thus limiting the growth.

It also resulted in control measures that impacted operations in life science organizations, such as…

The global market is facing a plethora of challenges. Travel bans and quarantines, halt of indoor/outdoor activities, temporary shutdown of business operations, supply demand fluctuations, stock market volatility, falling business assurance, and many uncertainties are somehow exerting a partial negative impact on the business dynamics.

The healthcare industry has been witnessing a number of cases of frauds, done by patients, doctors, physicians, and other medical specialists. Many…

The growing worldwide incidence of AKI/AKF is, therefore, expected to increase the demand for CRRT. According to the International Society of Nephrology (INR), an estimated 13.3 million cases of AKI are registered annually worldwide. This is anticipated to boost the adoption of continuous renal replacement therapy at a rapid rate. With the rapid growth in the geriatric population globally, the prevalence of kidney-related diseases is expected to increase significantly.

As the…